Evidence map›Paper›PMID 30890752›Full record

ArticleScientific reports2019

Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases.

Sergey O Bachurin, Galina F Makhaeva, Elena F Shevtsova, Natalia P Boltneva, Nadezhda V Kovaleva, Sofya V Lushchekina, Elena V Rudakova, Ludmila G Dubova, Daria V Vinogradova, Vladimir B Sokolov and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Sergey O BachurinInstitute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia.
Galina F MakhaevaInstitute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia.
Elena F ShevtsovaInstitute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia.
Natalia P BoltnevaInstitute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia.
Nadezhda V KovalevaInstitute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia.
Sofya V LushchekinaEmanuel Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, 119334, Russia.ORCID 0000-0002-6922-020X
Elena V RudakovaInstitute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia.
Ludmila G DubovaInstitute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia.
Daria V VinogradovaInstitute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia.
Vladimir B SokolovInstitute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia.
Alexey Yu AksinenkoInstitute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia.
Vladimir P FisenkoI.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119991, Russia.
Rudy J RichardsonDepartment of Environmental Health Sciences, University of Michigan, Ann Arbor, MI, 48109, USA.ORCID 0000-0002-2028-5723
Gjumrakch AlievInstitute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia. aliev03@gmail.com.
Institute of Physiologically Active Compounds · RUSechenov University · RUInstitute of Biochemical Physics NM Emanuel · RUUniversity of Michigan · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We studied the inhibitory activity of methylene blue (MB) γ-carbolines (gC) conjugates (MB-gCs) against human erythrocyte acetylcholinesterase (AChE), equine serum butyrylcholinesterase (BChE), and a structurally related enzyme, porcine liver carboxylesterase (CaE). In addition, we determined the ability of MB-gCs to bind to the peripheral anionic site (PAS) of Electrophorus electricus AChE (EeAChE) and competitively displace propidium iodide from this site. Moreover, we examined the ability of MB-gCs to scavenge free radicals as well as their influence on mitochondrial potential and iron-induced lipid peroxidation. We found that MB-gCs effectively inhibited AChE and BChE with IC

Indexed as

AcetylcholinesteraseAnimalsAntioxidantsBinding SitesButyrylcholinesteraseCarbolinesCarboxylesteraseCholinesterase InhibitorsErythrocytesHorsesHumansKineticsMethylene BlueMolecular Docking SimulationNeurodegenerative DiseasesSwineAcetylcholinesteraseAntioxidantsButyrylcholinesteraseCarbolinesCarboxylesteraseCholinesterase Inhibitorsgamma-carbolineMethylene Blue

Identifiers

PMID30890752
PMCPMC6424957
OpenAlexW2924486217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.